Literature DB >> 19226332

Epigallocatechin-gallate modulates chemotherapy-induced apoptosis in human cholangiocarcinoma cells.

Molly Lang1, Roger Henson, Chiara Braconi, Tushar Patel.   

Abstract

BACKGROUND: Green tea polyphenols are chemopreventive in several cancer models but their use as adjunctive therapeutic agents for cancer is unknown. AIMS: Cholangiocarcinomas respond poorly to chemotherapeutic agents and our aims were to assess the utility of green tea polyphenols as adjuncts to chemotherapy for cholangiocarcinoma.
MATERIALS AND METHODS: We assessed the effect of purified green tea catechins on chemotherapy-induced apoptosis in KMCH, CC-LP-1 and Mz-ChA-1 human cholangiocarcinoma cells, and on chemosensitivity of Mz-ChA-1 cell xenografts in nude mice.
RESULTS: Epigallocatechin-gallate (EGCG), but not the structurally related catechin epigallocatechin, sensitized cells to apoptosis induced by gemcitabine (GEM), mitomycin C or 5-fluorouracil in vitro. Mitochondrial membrane depolarization, cytosolic cytochrome c expression and apoptosis were increased in cells incubated with EGCG and GEM compared with either agent alone. Furthermore, EGCG decreased in vivo growth and increased the sensitivity to GEM of Mz-ChA-1 cell xenografts in nude mice.
CONCLUSIONS: The green tea polyphenol EGCG sensitizes human cholangiocarcinoma cells to chemotherapy-induced apoptosis and warrants evaluation as an adjunct to chemotherapy for the treatment of human cholangiocarcinoma.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19226332      PMCID: PMC3903791          DOI: 10.1111/j.1478-3231.2009.01984.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  39 in total

1.  Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States.

Authors:  T Patel
Journal:  Hepatology       Date:  2001-06       Impact factor: 17.425

2.  Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

Authors:  S D Taylor-Robinson; M B Toledano; S Arora; T J Keegan; S Hargreaves; A Beck; S A Khan; P Elliott; H C Thomas
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

3.  Inhibition of interleukin 6-mediated mitogen-activated protein kinase activation attenuates growth of a cholangiocarcinoma cell line.

Authors:  J Park; L Tadlock; G J Gores; T Patel
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

4.  Green tea polyphenol stimulates a Ras, MEKK1, MEK3, and p38 cascade to increase activator protein 1 factor-dependent involucrin gene expression in normal human keratinocytes.

Authors:  Sivaprakasam Balasubramanian; Tatiana Efimova; Richard L Eckert
Journal:  J Biol Chem       Date:  2001-11-06       Impact factor: 5.157

5.  Involvement of p38 mitogen-activated protein kinase signaling in transformed growth of a cholangiocarcinoma cell line.

Authors:  L Tadlock; T Patel
Journal:  Hepatology       Date:  2001-01       Impact factor: 17.425

6.  Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.

Authors:  Maryam R Sartippour; Zhi-Ming Shao; David Heber; Perrin Beatty; Liping Zhang; Canhui Liu; Lee Ellis; Wen Liu; Vay Liang Go; Mai N Brooks
Journal:  J Nutr       Date:  2002-08       Impact factor: 4.798

7.  Changing international trends in mortality rates for liver, biliary and pancreatic tumours.

Authors:  Shahid A Khan; Simon D Taylor-Robinson; Mireille B Toledano; Angus Beck; Paul Elliott; Howard C Thomas
Journal:  J Hepatol       Date:  2002-12       Impact factor: 25.083

Review 8.  Potential molecular targets of tea polyphenols in human tumor cells: significance in cancer prevention.

Authors:  Aslamuzzaman Kazi; David M Smith; Kenyon Daniel; Sherry Zhong; Puja Gupta; Marie E Bosley; Q Ping Dou
Journal:  In Vivo       Date:  2002 Nov-Dec       Impact factor: 2.155

Review 9.  Green tea consumption and liver disease: a systematic review.

Authors:  Xi Jin; Ruo-heng Zheng; You-ming Li
Journal:  Liver Int       Date:  2008-05-15       Impact factor: 5.828

10.  Worldwide trends in mortality from biliary tract malignancies.

Authors:  Tushar Patel
Journal:  BMC Cancer       Date:  2002-05-03       Impact factor: 4.430

View more
  17 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

Review 2.  Recent advances in the regulation of cholangiocarcinoma growth.

Authors:  Heather Francis; Gianfranco Alpini; Sharon DeMorrow
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-04-29       Impact factor: 4.052

3.  Capecitabine combined with (-)-epigallocatechin-3-gallate inhibits angiogenesis and tumor growth in nude mice with gastric cancer xenografts.

Authors:  Hongju Wu; Yan Xin; Chongan Xu; Yuping Xiao
Journal:  Exp Ther Med       Date:  2012-01-10       Impact factor: 2.447

Review 4.  Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma.

Authors:  Samuele De Minicis; Tatiana Kisseleva; Heather Francis; Gianluca Svegliati Baroni; Antonio Benedetti; David Brenner; Domenico Alvaro; Gianfranco Alpini; Marco Marzioni
Journal:  Dig Liver Dis       Date:  2012-11-22       Impact factor: 4.088

5.  Resveratrol enhances the sensitivity of cholangiocarcinoma to chemotherapeutic agents.

Authors:  Gabriel A Frampton; Eric A Lazcano; Huang Li; Akimuddin Mohamad; Sharon DeMorrow
Journal:  Lab Invest       Date:  2010-05-10       Impact factor: 5.662

6.  RNA interference targeting slug increases cholangiocarcinoma cell sensitivity to cisplatin via upregulating PUMA.

Authors:  Kejun Zhang; Dong Chen; Xingang Wang; Shaoyan Zhang; Jigang Wang; Yuan Gao; Bomin Yan
Journal:  Int J Mol Sci       Date:  2011-01-14       Impact factor: 5.923

7.  The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.

Authors:  Christian Mayr; Andrej Wagner; Daniel Neureiter; Martin Pichler; Martin Jakab; Romana Illig; Frieder Berr; Tobias Kiesslich
Journal:  BMC Complement Altern Med       Date:  2015-06-23       Impact factor: 3.659

8.  Capsaicin Enhances the Drug Sensitivity of Cholangiocarcinoma through the Inhibition of Chemotherapeutic-Induced Autophagy.

Authors:  Zai-Fa Hong; Wen-Xiu Zhao; Zhen-Yu Yin; Cheng-Rong Xie; Ya-Ping Xu; Xiao-Qin Chi; Sheng Zhang; Xiao-Min Wang
Journal:  PLoS One       Date:  2015-05-01       Impact factor: 3.240

9.  The green tea catechin epigallocatechin gallate (EGCG) blocks cell motility, chemotaxis and development in Dictyostelium discoideum.

Authors:  Kyle J McQuade; Akihiko Nakajima; April N Ilacqua; Nao Shimada; Satoshi Sawai
Journal:  PLoS One       Date:  2013-03-14       Impact factor: 3.240

10.  Preclinical demonstration of synergistic Active Nutrients/Drug (AND) combination as a potential treatment for malignant pleural mesothelioma.

Authors:  Viviana Volta; Elia Ranzato; Simona Martinotti; Simone Gallo; Maria Veronica Russo; Luciano Mutti; Stefano Biffo; Bruno Burlando
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.